LogoPressRelease.jpg
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
02 sept. 2021 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm to Present at Upcoming Health Care Investor Conference
10 nov. 2020 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of First Quarter 2020 Financial Results
20 avr. 2020 16h06 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Completes Acquisition of InstruNor AS
26 févr. 2020 08h30 HE | Fluidigm Corporation
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. ...
LogoPressRelease.jpg
Fluidigm to Participate in Upcoming Investor Conferences
12 févr. 2020 16h05 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results
10 févr. 2020 16h05 HE | Fluidigm Corporation
Fourth quarter revenue of $32.4 million Full year 2019 revenue increased 4 percent to $117.2 million; full year mass cytometry revenue increased 23 percent Landmark Nature publication demonstrates...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
10 oct. 2019 16h10 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO)
18 sept. 2019 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Human Proteome Organization (HUPO), an international scientific organization that promotes proteomics through international...
LogoPressRelease.jpg
Fluidigm to Participate in Upcoming Health Care Investor Conferences
20 août 2019 16h05 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results
02 août 2019 00h41 HE | Fluidigm Corporation
Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass...